G1 Therapeutics to Participate Virtually in the 2022 BTIG Biotechnology Conference and the 2022 Wedbush Pacgrow Healthcare Conference
Tuesday August 9, 2022, G1’s Chief Executive Officer Jack Baileyand other members of the executive team will participate in the virtual 2022 BTIG Biotechnology Conference. BTIG-hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest.
Wednesday August 10, 2022, Jack Baileyand other members of the executive team will participate in the virtual 2022 Wedbush Pacgrow Healthcare Conference. Mr. Baileywill participate in a “Commercial Oncology” panel at 8:35AM ET. The webcast and replay of this event will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.
G1 Therapeutics™ and the
Vice President, Investor Relations & Corporate Communications
Source: G1 Therapeutics